Corporate Attorney in New York : Merger

Due diligence is where most merger disputes originate. A buyer's legal team must investigate the target company's contracts, litigation history, regulatory compliance, and financial records. In practice, these investigations are rarely as clean as the checklist suggests. Courts in New York often grapple with disputes over what the buyer knew or should have known before signing the purchase agreement. A common client mistake is assuming that a preliminary financial audit covers all legal risk. It does not. Undisclosed environmental liabilities, pending employment claims, or breach of material contracts frequently emerge after closing, leaving the buyer with recourse only if the purchase agreement includes robust indemnification language.

As counsel, I advise clients that due diligence must be contemporaneous and thorough. The cost of a rigorous investigation now is far lower than litigation over breach of representations later. New York courts enforce merger agreements strictly, but they also recognize that parties allocate risk through the purchase agreement's representations, warranties, and indemnification provisions. Your corporate attorney in New York will coordinate with accountants, tax advisors, and industry specialists to ensure that legal due diligence captures the issues most likely to generate post-closing disputes.

Mergers can be structured as stock purchases, asset purchases, or statutory mergers, each with different tax consequences and liability implications. A stock purchase means the buyer assumes all liabilities of the target, known and unknown, unless the purchase agreement shifts that risk. An asset purchase is more selective but may trigger bulk transfer issues or leave behind unwanted liabilities in the seller's shell. Statutory mergers under New York Business Corporation Law Section 905 create a single surviving entity, but they must comply with specific procedural requirements.

The purchase agreement is the governing document for the entire transaction. It defines what the buyer is purchasing, what representations the seller makes, what happens if those representations are false, and how disputes are resolved. Key provisions include representations and warranties (what the seller certifies about the business), indemnification (the seller's obligation to reimburse the buyer for losses from breached representations), and closing conditions (what must occur before the buyer is obligated to close). Escrow holdbacks are common: the buyer withholds a portion of the purchase price in escrow for a defined period to cover potential indemnification claims.

From a practitioner's perspective, the negotiation of indemnification provisions is where deal economics are truly determined. A seller wants narrow indemnification baskets (the buyer must suffer losses above a threshold before claiming indemnity), short survival periods (representations expire quickly), and caps (the seller's total exposure is limited). The buyer wants the opposite: broad baskets, long survival periods, and high caps. New York courts enforce these provisions as written, so clarity and specificity matter enormously. Ambiguous indemnification language often leads to post-closing disputes in federal court or arbitration.

Our firm provides corporate transactions counsel to help clients structure purchase agreements that reflect their risk allocation preferences and withstand post-closing scrutiny. The agreement must also address representations regarding compliance with New York and federal law, including antitrust, securities, employment, and environmental statutes.

Regulatory approval is often the longest-lead item in a merger timeline. Antitrust review by the Federal Trade Commission or Department of Justice is mandatory if the transaction meets size thresholds under the Hart-Scott-Rodino Act. State regulatory approvals may also be required depending on the target's industry and assets. Telecommunications, banking, insurance, and healthcare mergers face heightened scrutiny. A merger that appears straightforward from a business perspective may trigger extended regulatory review or impose conditions that materially alter deal economics.

The most important decisions occur before the purchase agreement is signed. Once both parties have committed, the deal momentum becomes difficult to reverse. Early strategic decisions include target valuation and purchase price adjustment mechanisms, earnout provisions (contingent payments based on post-closing performance), management retention and incentive alignment, and integration planning. Earnouts create ongoing disputes because the buyer controls the target's post-closing operations and has incentives to minimize earnout payments. New York courts enforce earnout provisions, but disputes over whether the buyer acted in good faith to achieve earnout targets are common.

Practical example: A buyer acquires a software company for $50 million plus an earnout of up to $10 million over two years based on revenue targets. The purchase agreement requires the buyer to use commercially reasonable efforts to achieve the targets. After closing, the buyer integrates the software into its platform and reallocates sales resources. Revenue falls short of the earnout target. The seller sues, claiming the buyer breached its duty of good faith. New York courts will examine whether the buyer's integration decisions were commercially reasonable or were designed to suppress earnout payments. This is where disputes most frequently arise, and the outcome depends heavily on how the trial judge weighs the facts.

Our corporate law team helps clients evaluate whether earnout structures align incentives or create future litigation risk. Before signing the agreement, you should also assess integration challenges, employee retention and benefits continuation, customer notification and contract assignment, and post-closing indemnification insurance.

Merger transactions demand early engagement with counsel who understands both the business drivers and the legal complexities. The decisions you make in the first 60 days—target selection, preliminary valuation, deal structure, and regulatory strategy—will determine whether the transaction creates shareholder value or becomes a source of post-closing disputes and litigation. Your corporate attorney in New York should help you map those decisions and build a transaction timeline that accounts for regulatory timelines, due diligence depth, and integration complexity.